Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Newtopia Inc

Healthcare CA NEWU

NoneCAD
0.00(0%)

Last update at 2026-04-02T21:05:21.537310Z

Day Range

--
LowHigh

52 Week Range

0.0050.005
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap0.87M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-2.73182M
  • Revenue TTM6.71M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 3.35M
  • Diluted EPS TTM-0.04

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -6.60035M -7.70046M -7.64975M -7.73185M -10.14059M
Minority interest - - - - -
Net income -6.60035M -7.70046M -7.64975M -7.73185M -10.14059M
Selling general administrative 7.43M 10.90M 11.61M 8.65M 6.95M
Selling and marketing expenses - - - - -
Gross profit 5.28M 6.03M 5.07M 5.50M 1.97M
Reconciled depreciation 0.83M 0.28M 0.25M 0.27M 0.24M
Ebit - - -7.21441M -6.85680M -7.73457M
Ebitda - -7.02362M -7.21089M -7.08991M -7.10072M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -2.59596M -6.43811M -7.21441M -6.85680M -7.73457M
Other operating expenses - - - - -
Interest expense 0.94M 0.39M 0.19M 0.38M 2.80M
Tax provision - - - - -
Interest income - - - - -
Net interest income -1.59540M -0.91479M -0.42924M -0.38987M -2.80540M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 9.78M 11.17M 10.46M 11.42M 6.11M
Total operating expenses 12.38M 17.60M 17.67M 18.27M 13.84M
Cost of revenue 4.51M 5.14M 5.38M 5.91M 4.14M
Total other income expense net -2.40899M -0.34756M -0.00611M -0.48518M 0.40M
Discontinued operations - - - - -
Net income from continuing ops -6.60035M -7.70046M -7.64975M -7.73185M -10.14059M
Net income applicable to common shares - - -7.64975M -7.73185M -10.14059M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 2.33M 5.94M 5.51M 7.90M 5.63M
Intangible assets - 3.24M - - -
Earning assets - - - - -
Other current assets - - 0.16M 0.23M -
Total liab 11.75M 11.48M 7.35M 3.70M 16.84M
Total stockholder equity -9.41866M -5.53366M -1.84431M 4.20M -11.21248M
Deferred long term liab - - - - -
Other current liab - - 0.20M 0.05M 2.13M
Common stock - - 45.18M 44.65M 4.64M
Capital stock 49.40M 47.98M 45.18M 44.65M 17.65M
Retained earnings -72.97444M -66.37410M -58.67363M -51.02388M -43.20438M
Other liab - - - - -
Good will - - - - -
Other assets - - - - -
Cash 0.39M 0.35M 0.81M 4.67M 2.39M
Cash and equivalents - - - - -
Total current liabilities 10.36M 10.41M 4.80M 2.62M 15.96M
Current deferred revenue - - - - -
Net debt 9.49M 7.96M 3.70M - 1.61M
Short term debt - - - - -
Short long term debt 8.49M 7.23M 2.33M - 3.99M
Short long term debt total - - - - -
Other stockholder equity - - - 0.53M 9.16M
Property plant equipment - - 0.44M 0.68M 0.93M
Total current assets 2.33M 2.70M 2.82M 6.74M 4.70M
Long term investments - - - - -
Net tangible assets - - -4.09617M 4.13M -24.22352M
Short term investments - - - - -
Net receivables 1.33M 1.49M 1.38M 1.09M 1.25M
Long term debt 1.39M 1.07M 2.18M - -
Inventory 0.12M 0.33M 0.13M 0.28M 0.60M
Accounts payable 1.83M 2.58M 1.39M 1.58M 1.25M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.00466M 3.24M 2.69M 0.75M 0.93M
Capital lease obligations 0.00000M 0.54M 0.67M 0.88M 1.04M
Long term debt total - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -0.00255M -0.98918M -2.14653M -0.09278M -0.16339M
Change to liabilities - - -0.03467M 0.55M 1.05M
Total cashflows from investing activities - - -2.14653M -0.09278M -0.16339M
Net borrowings 0.73M - 4.55M -0.29967M -0.36411M
Total cash from financing activities 2.31M 6.44M 4.23M 7.17M 6.65M
Change to operating activities - - 0.13M -0.00268M -0.20431M
Net income -6.60035M -7.70046M -7.64975M -7.73185M -10.14059M
Change in cash 0.04M -0.46563M -3.86210M 2.29M 0.96M
Begin period cash flow 0.35M 0.81M 4.67M 2.39M 1.43M
End period cash flow 0.39M 0.35M 0.81M 4.67M 2.39M
Total cash from operating activities -2.26974M -5.91522M -5.94936M -4.78518M -5.53164M
Issuance of capital stock 1.47M - - - -
Depreciation 0.83M 0.28M 0.25M 0.27M 0.24M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.21M -0.19457M 0.15M 0.33M -0.20555M
Change to account receivables - - -0.15201M 0.16M -0.65507M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - -0.31328M -0.16078M 7.02M
Change to netincome - - 1.18M 1.63M 4.38M
Capital expenditures 0.00255M 0.99M 0.00282M 0.02M 0.16M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -0.15794M 0.20M 0.10M 1.03M -0.01409M
Stock based compensation 0.56M 0.49M 1.07M 0.77M 2.02M
Other non cash items 0.69M 0.59M 0.31M 0.39M 2.80M
Free cash flow -2.27229M -6.90439M -8.09589M -4.87796M -5.69503M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
NEWU
Newtopia Inc		 - -% - - - 0.13 99.08 1.74 -2.5615
NURS
Hydreight Technologies Inc		 -0.29 5.58% 4.91 406.00 25.91 7.85 20.38 7.45 109.02
RHT
Reliq Health Technologies Inc		 - -% 0.21 - - 3.19 5.12 4.07 -10.7759
ADK
Diagnos Inc		 -0.01 4.35% 0.22 - 10.00 411.24 18.74 389.06 -6.1551
NXG
NexgenRX Inc.		 -0.01 2.27% 0.43 39.00 32.68 1.55 4.64 1.39 7.84

Reports Covered

Stock Research & News

View All

Profile

Newtopia Inc. operates as a tech-enabled whole health platform primarily in the United States. Its platform leverages genetic, social, and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management, and musculoskeletal disorders. Newtopia Inc. was incorporated in 2008 and is headquartered in Toronto, Canada.

Newtopia Inc

33 Bloor Street East, Toronto, ON, Canada, M4W 3H1

Key Executives

Name Title Year Born
Mr. Jeffrey Ruby J.D. Founder, CEO & Chairman 1975
Ms. Lara Dodo Chief Growth Officer & COO NA
Mr. William J. Van Wyck CTO & Head of Product 1966
Mr. Peter Seider Chief Information, Privacy & Security Officer and Head of Technology Operations 1968
Mr. Edmond Lem Controller & Sr. VP of Fin. 1966
Mr. Collin Swenson Chief Financial Officer NA
Mr. Rob Halpern Sr. VP of Marketing NA
Dr. Karyn Hood C. Psych, Ph.D. Head of Behavioral & Mental Health NA
Ms. Rikki Bennie Sr. VP (Leave of Absence) 1954
Dr. Michele Dodds Sr. VP of Client & Participant Success 1970

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions